Long-term prognosis and cost-effectiveness of left ventricular assist device as bridge to transplantation: A systematic review

LVADs used as BTT did not significantly alter post-transplantation long-term survival, rejection, and post-operative morbidity. LVAD BTT may be cost-effective, particularly in medium and high-risk patients with expected prolonged waiting times, renal dysfunction, and young patients.